Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
human growth hormone-releasing peptide 3
- Development stage
- Phase 2
- Modality
- Peptides
- Administration
- Intravenous
01
Overview
Human growth hormone-releasing peptide 3 (GHRP-3) is a synthetic peptide that stimulates growth hormone (GH) secretion from the pituitary gland. It belongs to the class of growth hormone-releasing peptides (GHRPs) that have potent stimulatory effects on the GH-IGF-I system. GHRP-3 is a small C-terminally amidated peptide comprising four to seven amino acid residues.
- Other names
- L-argininamide, 2-methylalanyl-d-tryptophyl-d-prolyl-d-isoleucyl-
02
Targets
GHSR (Growth hormone secretagogue receptor)
Beyond the preview
Go deeper on human growth hormone-releasing peptide 3.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on human growth hormone-releasing peptide 3.